The pharmaceutical and chemical industries have long relied on animal testing to determine the safety and efficacy of new drugs. However, this practice is not only ethically questionable, but also time-consuming and costly. Fortunately, there is a groundbreaking solution in development – the LIFESAVER Project utilises a new “biodigital twin” system with a high biofidelity for regulatory, societal, healthcare and industry approval. Considering that premature birth kills one baby every thirty seconds worldwide, this technology currently being developed is not only going to be saving animals, it will ultimately save babies too.
The Lifesaver Project is innovative and unique in many ways. Not only does it seek to lead the vanguard in pregnant women health research, but it also aims to do this excluding animal testing. If Lifesaver’s bio-digital twin system that replicates the behaviour of the human placenta for drugs and chemicals transmission proves as effective as we believe it will, could this spell the end for animal testing in the future?